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An approach using the attributable fraction (AF) has been developed to estimate the current burden of occupational cancer in Britain.
The AF combines the relative risk (RR) associated with exposure with the proportion exposed. For each cancer–exposure pairing,
the RR is selected from key epidemiological literature such as an industry, or population-based study, meta-analysis or review. The
CARcinogen EXposure (CAREX) database provides point estimates for the number of workers exposed to a range of carcinogens;
alternative sources are national surveys such as the Labour Force Survey and Census of Employment. The number of workers
exposed are split between high and low exposure levels matched to appropriate RRs from the literature. The relevant period for
cancer development during which exposure occurred is defined as the risk exposure period (REP). Estimation of the numbers ever
exposed over the REP takes into account the changes in the number of people employed in primary and manufacturing industry and
service sectors in Britain where appropriate, and adjustment is made for staff turnover over the period and for life expectancy.
National estimates of the population ever of working age during the REP are used for the proportion denominator. Strategies have
been developed to combine exposure AFs correctly while avoiding double counting and minimising bias. The AFs are applied to
national cancer deaths and registrations to obtain occupation-attributable cancer numbers. The methods are adaptable for other
diseases and other geographies, and are also adaptable to more sophisticated modelling if better exposure and dose–response data
are available.
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Doll and Peto (1981) estimated the proportion of cancer deaths in
Britain due to occupational causes as 4% (with an uncertainty
range from 2 to 8%), which equates to B6000 deaths per annum
(with a range of 3000–12000). The aim of this project was to
update the estimate of the burden of cancer in Britain due to
occupation. Several different approaches are available to calculate
attributable cancer burden. However, for this study, the occupa-
tion-attributable fraction (AF), that is, the proportion of total
cancers that would not have occurred in the absence of
occupational exposures, was used. This required estimation of
the risk of the disease associated with the carcinogen of interest
(e.g., the relative risk (RR)) and also the proportion of the
population exposed to the carcinogen of interest. In this paper, the
methodology developed for this project is described. The methods
are illustrated in the accompanying papers in this supplement. The
strengths and weaknesses (i.e., sources of bias and uncertainty) of
this methodology are discussed, as well as interpretation of the
results. More detail of the methodology is provided in the Health
and Safety Executive technical report (HSE, 2011).
METHODOLOGY
The overall AF was calculated on a ‘cancer-by-cancer’ basis.
Relative risks were obtained from currently available epidemio-
logical studies that were considered the most appropriate.
The choice of these ‘best studies’ then determined the method
by which AF was calculated.
Identifying the occupational exposures
For each cancer, major literature sources were reviewed to identify
relevant occupational exposures, confounders and other non-
occupational risk factors, and to obtain information on latency and
trends in mortality, incidence and survival. At two international
workshops held as part of the project to discuss the methodology
(HSE, 2005, 2007), the participants advised that priority should be
given initially to International Agency for Research on Cancer
(IARC) Group 1 and 2A occupation-related carcinogens and
occupational circumstances (e.g., occupation as a painter). Agents
or occupations in these IARC groups were included that had either
‘strong’ or ‘suggestive’ evidence of carcinogenicity in humans for
the specific cancer site, as defined by Siemiatycki et al (2004) and
subsequent IARC publications. In addition, there had to be
substantial existing exposures in Britain and/or cases of cancer still
occurring due to past exposures.
It is quite common for workers to be exposed over a working
lifetime to several occupational carcinogens able to cause cancer at
a single site. It is incorrect to estimate separately the contribution
towards the overall AF of these overlapping exposures. These
exposures should ideally be treated as a set, and a study sought
that has RR estimates for the set as a whole or a study that takes
account of the confounding effects and interactions within the set. *Correspondence: SJ Hutchings; E-mail: s.hutchings@imperial.ac.uk
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account of potential multiple exposures, an ‘exposure map’ was
drawn up for each cancer site (e.g., Figure 1 for bladder cancer) in
order to illustrate the potential for double counting of the exposed
population, and our strategies to deal with the problem included
partitioning exposed numbers between overlapping exposures or
estimating only for the dominant carcinogen with the highest risk
(Van Tongeren et al, 2012).
For each cancer–exposure pairing, the approach in general was
to partition the exposed population between ‘higher exposure’ and
‘lower’ and/or ‘background exposure’ groups, and to apply an appro-
priate RR from the source study or studies to each group separately.
Choosing RRs
Literature searches were carried out for relevant papers for the
selection of RRs. Standard search criteria were used, supplemented
by references from review papers and textbook bibliographies. A
set of criteria was developed and applied for selecting appropriate
RRs from the literature, taking into account the quality of the
published study and portability to the British situation. Important
issues concerning portability (Steenland and Armstrong, 2006)
included: (1) similarity of the published study populations with
respect to the nature and levels of exposures – it would be
preferable to use British studies or those from countries with a
similar industrial heritage and level of development; (2) relevance
of the source study exposure period to the target risk exposure
period (REP) in the burden estimation (see below); (3) similarity
of the distribution of known confounders, for example, smoking,
in the published study source population and the British target
population.
Time limitations restricted the use of systematic review methods
for every cancer site/occupational carcinogen or circumstance.
Combined studies (pooled studies and meta-analyses) were thus
usually the first choice if available, with UK studies added if
necessary. The RRs for use in the calculation of AF were identified
and extracted from the chosen studies. Relative risks adjusted for
important confounding factors, and for interaction effects with the
exposures of interest, were preferred. Where only a narrative
review was available, giving a range of risk estimates from several
relevant studies, we calculated a combined estimate of the RRs,
(i) for homogeneous RRs, based on a fixed-effects model using a
precision (inverse variance) weighted average (Breslow and Day,
1989; Rothman and Greenland, 1998), or, (ii) for heterogeneous
RRs, based on a random-effects model, using methods described
by DerSimonian and Laird (1986). Formal systematic reviews and
meta-analyses were carried out to estimate RRs for laryngeal and
stomach cancers related to asbestos exposure.
Dose–response risk estimates were generally not available in the
epidemiological literature, nor were proportions of those exposed
at different levels of exposure over time available for the working
population in Britain. However, where possible, risk estimates
were obtained for an overall ‘lower’ level and an overall ‘higher’
level of exposure to the agents of concern. Where no risk estimate
could be identified for very low/background levels of exposure, we
estimated a RR for the ‘lower-exposed’ group by (i) taking the
harmonic mean of all the available ratios of ‘higher’ to ‘lower’ RR
estimates for cancer exposure pairs for which data were available
and (ii) applying this average ratio to the ‘higher’-level estimates to
obtain ‘lower’-level RR estimates. If the resulting RR estimate was
o1, RR was set to 1.
The REP
We defined the REP, based on cancer latency, as the window of
time during which exposure to an occupational carcinogen could
result in a cancer being diagnosed or appearing in national
mortality or cancer registration records. As there was very little
data available on cancer latency for occupational carcinogens, two
REPs were assumed for this study: for solid tumours a latency
between 10 and 50 years and for haematopoietic malignancies,
such as leukaemia, a latency between 0 and 20 years. For deaths in
our target year of 2005, this gives a REP of 1956–1995 for solid
tumours and of 1986–2005 for haematopoietic malignancies.
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Figure 1 Example of an exposure map for bladder cancer. Carcinogenic agents are in plain type, and exposure scenarios in italics. Lines joining boxes
indicate where overlap occurs; industries and occupational circumstances where overlap occurs are indicated in smaller print. For substances and
occupations shown in boxes with dotted lines, a separate AF was not estimated, as these exposure scenarios were included with another dominant
exposure.
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recorded in 2004, the year for which estimation has been carried
out, would be 1955–1994, for simplification the years for deaths
1956–1995 have also been used, as the proportion exposed will not
be affected. Data specific to these REPs are given in Table 1.
Estimating the proportion exposed
If the RR was extracted from a population-based published study,
an estimate of the proportion of the population exposed was taken
directly from the study. It would be particularly important in this
case that the study population was comparable and portable to
Britain. In practice, population-based studies were rarely available.
If the RR was extracted from an industry-based study, national
data sources such as the CARcinogen EXposure database (CAREX;
Pannett et al, 1998) or the UK Labour Force Survey (LFS, 2009)
and Census of Employment (ONS, 2009) were used as a basis for
estimating the exposed population. For 139 carcinogens, CAREX
gives both the total numbers and the number of people exposed by
industrial sector for the period 1990–1993. In practice, for expo-
sures not covered by CAREX, there was rarely a good alternative
estimate of the proportions in the workplace exposed; estimates
of the number of people employed in a relevant occupation using
the narrowest possible definition of this occupation (from the
Labour Force Survey) or industry (Census of Employment or
Labour Force Survey) were then used. Exposed numbers from
CAREX or national employment sources were allocated to a
‘higher’- or ‘lower’-exposure group, assuming distributions of
exposure and risk that corresponded broadly to those of the
studies from which the risk estimates were selected. The initial
allocations were based on the judgment of an experienced human
exposure scientist; each assessment was then independently
peer-reviewed and, if necessary, a consensus assessment agreed
(Van Tongeren et al, 2012).
Data from CAREX are not differentiated by sex, and thus they were
split between men and women according to an estimate of relative
proportions in major Standard Occupational Classification (SOC)
groups based on numbers from the 1991 Census. The most often used
were: blue-collar workers (SOC major groups 5, 8 and 9) covering
skilled trades, shop floor and transport operatives; white-collar
workers (SOC major groups 1, 2 and 4) covering managerial,
professional, administrative and secretarial; and associate profes-
sional, technical, personal and customer service occupations (SOC
major groups 3, 6 and 7). In practice, the percentage most appropriate
to the particular exposure scenario has been used, with flexibility to
use percentages for single rather than grouped SOC major groups if
exposed numbers were clearly concentrated in these occupations.
Transport operatives (SOC group 8) in the service industries
( i n d u s t r i a ls e c t o r sG - Q )w e r ea ne x a m p l eo ft h ea p p r o p r i a t eu s eo f
a single SOC group for exposure to diesel engine exhaust.
Table 1 Values of variables used in the calculation of attributable fraction specific to the risk exposure periods
Risk exposure period Solid tumours Haematopoietic malignancies
Variable Men Women Men Women
Latency 10–50 years 10–50 years 0–20 years 0–20 years
Risk exposure period 1956–1995 1956–1995 1986–2005 1986–2005
Peak latencya 35 years 35 years 15 years 15 years
Number of years in risk exposure period 40 40 20 20
Total number of those ever of working age during
the risk exposure period, and alive in 2005
19.4 million 21.0 million 23.0 million 23.1 million
Ages included 25–90+ 25–90+ 15–84 15–79
aPeak latency is the latency thought to relate to the highest number of cancer cases leading to current deaths or registrations.
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Figure 2 Labour Force Survey employment by grouped main industrial sector, A–Q.
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exposed, the number of workers ever exposed during this period
was estimated by extrapolating from a point estimate of exposed
workers taken from the period. CAREX data for Britain relate only
to the period 1990–1993, and this was the point-estimate year used
for these data. For solid tumour cancers where CAREX data were
used, adjustment factors were applied to take into account the
change in number of people employed in the primary and
manufacturing industry and service sectors in Britain between
the late 1970s and early 1990s. The factors were estimated from
Labour Force Survey employment data, and were grouped by main
industrial sector and for men and women separately. The trends
on which the factors were based are illustrated in Figure 2, and the
factors are given in Table 2. For the Labour Force Survey and
Census of Employment, an available year was chosen to represent
the number of people employed about 35 years before the target
year of 2005, as this was thought to represent a peak latency for the
solid tumours, and is also close to the midpoint of the REP for
estimating the number of people ever exposed across the period (for
which a linear change in employment levels was implicitly assumed).
In instances where the Census of Employment was used, the point-
estimate data were for 1981 for solid tumours. In instances where the
Labour Force Survey was used, the first year available was 1979 for
solid tumours, and the data for 1991 was used for short latency
malignancies.
Staff turnover factors were applied to the point estimates of the
number of people exposed that were specific to the same grouped
main industrial sectors as the CAREX adjustment factors. The
turnover factors were estimated using Labour Force Survey data
for the length of time with the current employer; this was available
by length of employment category, and was used to estimate
numbers of new starters per year. Ideally, an estimate of staff
turnover requires full national starter and leaver data across the
REP for all industrial sectors. In the absence of this quality of data,
estimating turnover directly using new starters in years within the
REPs gives the best approximation for the purpose of estimating
those ever exposed. This method estimates starters in the past year
as a proportion of the average number of people employed (Gregg
and Wadsworth, 2002). Exposure in occupational epidemiological
studies is very often defined as that for at least 1 year; we have
adapted this method therefore to exclude short-term labour
turnover by taking new starters in the past year who are expected
to remain employed for at least 1 year as a proportion of all those
expected to be employed for at least 1 year. This is estimated as the
number of people recorded as employed between 1 and 2 years
divided by the total number of people employed for at least 1 year
using Labour Force Survey data averaged over the REP.
The number of people ‘ever exposed’ during the REP, Ne(REP),
taking into account turnover is as follows:
NeðREPÞ ¼ n0 þf n0   TO   tgð 1Þ
where n0 is the number of people employed at the midpoint of the
REP, TO is staff turnover per year and t is the number of years in
the REP.
Life table estimates of the proportions of the general population
surviving to the target year (2005) were used to adjust Ne(REP),
so that only the ever exposed cohort members surviving to the
target year would be counted. This assumed that there was an
even distribution of ages across the exposed cohort in its first
Table 2 Factors used for adjusting CAREX exposed numbers to the risk exposure period (solid tumour cancers), and staff
turnover factors used in the calculation of numbers ever exposed
Main industry sector CAREX
adjustment factor
Annual Staff
Turnover (TO)
Turnover factors based on a 40-year
(long latency) and 20-year
(short latency) risk exposure period
and GB life expectancy tables
Long latency risk
exposure period
Short latency risk
exposure period
Men
A, B Agriculture, hunting and
forestry; fishing
1 0.07 3 2
C, D, E Mining and quarrying,
electricity, gas and water;
manufacturing industry
1.4 0.09 3 3
F Construction 1 0.12 4 3
G-Q Service industries 0.9 0.11 4 3
Total 1 0.10 4 3
Women
A, B Agriculture, hunting and
forestry; fishing
0.75 0.10 4 3
C, D, E Mining and quarrying,
electricity, gas and water;
manufacturing industry
1.5 0.14 5 4
F Construction 0.67 0.15 6 4
G–Q Service industries 0.8 0.15 6 4
Total 0.9 0.14 6 4
Abbreviations: CAREX¼CARcinogen Exposure; GB¼Great Britain; TO¼turnover.
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to the cohort was in the age range of 15–24 only. The equation
becomes:
NeðREPÞ ¼
X i¼b
i¼a
flðadj15Þi   n0=ðR   15Þg
þ
X k¼ðageðuÞ ageð1ÞÞ
k¼0
X j¼dþk
j¼cþk
flðadj15Þj   n0   TO=ðageðuÞ ageðlÞþ1Þg
ð2Þ
where n0 is the point estimate of the number of people employed at
a midpoint of the REP (adjusted for the CAREX data using factors
in Table 2).
TO is staff turnover per year (see Table 2),
R is retirement age (taken here as 65 for men, 60 for women),
l(adj15)i is the proportion of survivors up to age i (the li) from the
sex- and time-appropriate British Life Table data (1980–1982 for
the solid tumour REP, 1994–1996 for the short latency REP) (GAD,
Interim Life Tables, 2007), adjusted to include only those still alive
at the age of 15 years by taking l(adj15)i¼li/l15,
a to b is the age range achieved by the original cohort members
by the target year (e.g., a¼65, b¼100 for the solid tumour
standard REP; a¼35, b¼84 (men, b¼79 for women) for the short
latency standard REP),
c to d is the age range achieved by the turnover-recruited cohort
members by the target year (c¼25, d¼64 for the solid tumour
standard REP; c¼15, d¼34 for the short latency REP),
age(u) and age(l) are the upper and lower recruitment age limits
(15–24 used here).
The last column of Table 2 gives the turnover factors for each
major industrial sector obtained by dividing Ne(REP) by n0. These
are of similar magnitude to those used in the Global Burden of
Disease methodology (Nelson et al, 2005).
For some exposures, an industrial process was known to have
changed at a certain time during the REP, or controls had been put
in place to reduce exposure. In this case, different RRs were
used for each period. To partition the estimate of number of
people ever exposed between the two periods, the age ranges c to d
in equation (2) were adjusted in the turnover-recruited part of the
equation to suit the restricted time period, and members of the
original cohort are only counted once, that is, in the first period.
To estimate the proportion of the population exposed, the
estimated number of people ‘ever exposed’ during the REP was then
divided by the total population ever of working age during the same
period (Table 1). This was based on national population estimates
by age cohort in the target year, obtained by summing the age
cohorts 25–34 to 90þ for the solid tumour REP and 15–24 to
80–84 for the short latency REP for men (75–79 for women).
Calculating the AF
If the RR was extracted from a population-based study, the
estimate of the proportion of cases exposed was extracted directly
from the study, and Miettinen’s equation (Miettinen, 1974) was
used for calculating the AF:
AF ¼ PrðEjDÞ ð RR   1Þ=RR ð3Þ
where Pr(E|D) is the proportion of cases exposed (E¼exposed,
D¼case).
For RRs from industry-based studies, with an estimate of
the proportion of the population exposed from an independent
data source, Levin’s equation was used to calculate the AF
(Levin, 1953):
AF ¼ PrðEÞ ð RR   1Þ=f1 þ PrðEÞ ð RR   1Þg ð4Þ
where Pr(E) is the proportion of the population exposed.
Levin’s and Miettinen’s equations are equivalent, and can be
derived from one another using the definition of RR and Bayes
theorem (Benichou, 2001).
Separate AFs were calculated by industry/occupation and for the
‘higher’ and ‘lower’-exposed groups, and then summed to give an
overall AF for the specific cancer–exposure pair. The form of
the equation used for multiple exposure levels h, separate
industries i and time periods j for Levin’s estimator was
AF ¼f ShSiSj PrðEhijÞðRRhj   1Þg=f1 þf ShSiSj PrðEhijÞðRRhj   1Þg
ð5Þ
Note that in practice separate AFs are estimated by exposure level,
industry and time period, but a common denominator must be
used that incorporates all the estimates of proportions of the
population exposed and RRs, which contribute to the final
exposure-AF in each estimate.
For a few cancer–exposure pairings, alternative approaches
were used to estimate attributable numbers and hence AF. The AF
for mesothelioma was derived directly from several UK mesothe-
lioma studies that suggest that between 96 and 98% of male
mesothelioma cases are due to occupational or paraoccupational
exposure (e.g., exposure from living near an asbestos factory or
handling clothes contaminated because of occupational exposure)
(Howel et al, 1997; Yates et al, 1997; Rake et al, 2009). Combining
the results from Rake et al (2009) with those from two studies in
which results were reported separately for women (Spirtas et al,
1994; Goldberg et al, 2006) gave estimates of 75–90% for women.
To allocate total mesotheliomas between separate industries,
industry-specific AFs calculated in the usual way were used to
estimate the proportions between industries, but mesotheliomas
considered to be paraoccupational (6–13% of the total for men,
45–70% for women) were excluded from the allocation. The ratio
of asbestos-related lung cancer to mesothelioma deaths has been
suggested to be between two-thirds and one (Darnton et al, 2006).
We therefore used a ratio of 1:1 mesothelioma to lung cancer
deaths for the estimation of the number of lung cancers
attributable to asbestos. This takes into account the impact that
past levels of asbestos exposure are having on current incidence by
the direct link to mesothelioma deaths that are still increasing,
whereas lung cancer in general is declining owing to the reduction
in smoking. This assumes, however, that lung cancer has a similar
pattern of latency to mesothelioma.
Specialised methods were also used to calculate the AF for lung
cancer due to radon exposure, based on estimates of the number of
people developing lung cancer from exposure to radon in domestic
buildings (HSE, 2005).
The risk estimates for occupational exposure to ionising
radiation were derived using generalised linear dose–response
models of excess RR per unit of cumulative radiation dose from
the United Nations Scientific Committee on the Effects of Atomic
Radiation (UNSCEAR 2006) (UNSCEAR, 2008), and were therefore
applied to cumulative lifetime dose estimated using data from the
Central Index of Dose Information (CIDI; HSE, 1998). For aircrew,
who are not covered by CIDI, the mean total lifetime radiation
dose per pilot was obtained from a large cohort study of European
airline pilots (Langner et al, 2004) and combined with the number
of people employed, obtained from the British Airways Stewards
and Stewardesses Union (BASSA, 2008).
Combining the AFs
A number of strategies were adopted for combining AFs for several
occupational exposures causally related to a specific cancer.
Attributable fractions cannot generally be summed directly
because (1) summing AFs for overlapping exposures (i.e., agents
to which the same ‘ever-exposed’ workers may have been exposed)
may give an overall AF exceeding 100% and (2) summing disjoint
Occupational cancer in Britain
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bias. This bias can only be eliminated by using an alternative
formulation of Levin’s equation, which requires information from
the other disjoint exposures in the denominator.
If it could be assumed that overlapping exposures were
independent and their joint effect on initiating or promoting
cancer was multiplicative, that is, RR(exp 1 and exp 2)¼RR(exp 1) 
RR(exp 2), the AFs for each exposure in the overlapping set
were combined into an overall AF for the set by taking the
complement of the product of complements (Steenland and
Armstrong, 2006):
AFoverall ¼ 1   Pkð1   AFkÞforthekexposuresintheset: ð6Þ
This equation is also used for combining disjoint exposure AFs, as
it can be shown that this introduces less bias into the results
compared with, for example, direct summing of the AFs.
As explained earlier, if it was not appropriate to assume
independence of overlapping exposures, a dominant exposure
industrial sector was chosen (Figure 1). Equation (6) was then used
to combine the now disjoint exposure AFs.
Estimating attributable numbers
Attributable number of deaths and cancer registrations for the
most recent year available at the time of the study for a specific
cancer site were estimated by multiplying the AF by the total
British (EnglandþWalesþScotland) cancer-specific deaths
(2005; ONS, 2006) and registrations (2004; ONS, 2007), respec-
tively. Data were not always available for some short latency
malignancy sub-types (e.g., some leukaemia sub-types in the
Welsh and Scottish data). In this case, sub-type proportions in
English data or other sources were used. For solid tumours, only
cancers in people aged 25 years and above were counted, as these
could have been initiated during the REPs being considered.
For haematopoietic malignancies, only people aged 15 to 20 years
beyond retirement age were included (84 for men as the state
retirement age was 65 and 79 for women as the state retirement
was 60).
Combining the AFs across cancer sites
To obtain the overall occupation-AF, that is, burden, attributable
numbers for each cancer were summed and divided by total cancer
numbers. This assumes that there is no overlap between cancer
sites and that a single exposure is very unlikely to produce more
than one primary cancer in an individual at a specific time. An
overall AF for each exposure or each exposure level over all the
cancer sites affected by that exposure was estimated in a similar
way. It should be noted that attributable numbers should not be
summed across different exposures for a specific cancer site; they
are estimated by applying the combined AF from equation (6) to
totals for that cancer site.
Confidence interval for the overall AF
A 95% random error only confidence interval was calculated for
each AF, based only on the variability of the RR estimates used,
and using Monte Carlo simulation methods where more than one
RR estimate was involved (Greenland, 2004). A total of 100000
replicates were generated from a log-normal distribution with
mean and standard deviation based on the point estimate and
standard error for each RR, and then applied to the equation used
to calculate the AFs. The 97.5 and 2.5 percentiles from this sample
of AFs gave the 95% confidence intervals.
DISCUSSION
A number of assumptions have been made for this study. For the
standard REPs, we have assumed a latency period of 10–50 years
for solid cancers and for haematopoietic malignancies 0–20 years
is assumed. There are limited data available on length of cancer
latency, and it has been assumed that latency for cancer due to
occupational exposure is the same as that due to all exposures in
general.
For estimating the number of people ever exposed, it is assumed
that there was an even distribution of ages across the cohort of
exposed workers in the first year of the REP, and that recruitment
to the cohort through turnover was into the youngest age range
(15–24) only. It would be possible to adjust the AF estimator to
take into account the ages the exposed workers have reached by
the target year as a result of making these assumptions, and
therefore to take into account their differential (age-related) cancer
rates. The effect of making these age adjustments would be
to reduce attributable numbers as the workers at risk have a
younger age profile that the general population of workers in
the REP. However, this would be offset by the higher estimates of
attributable cancers that result from more exposed workers
surviving up to the target year and hence at risk for a long latency
cancer. The effect is illustrated in Figure 3 for a range of possible
recruitment age bands; it is noticeable that there is very little
difference between using our (15–24) age recruitment assumption
without age adjustment of the AF estimator and using older age
recruitment assumptions with age adjustment.
It has also been assumed that survival as a result of occupational
exposures was similar to survival as a result of non-occupational expo-
sures, as incidence and mortality RRs have been used interchangeably.
There is also simplicity in our approach to estimating the
numbers and proportions of the population ‘ever exposed across
the REP’. Firstly, common assumptions regarding the REP and age
structure of the workforce have been used. Secondly, a common set
of standardised factors has been used to account for historical
changes in GB employment patterns and staff turnovers by
industrial sector and for men and women. These estimates are
realistic and information based (principally Labour Force Survey
data). Thirdly, incorporating survival to the target year (2005) was
also important to make realistic estimates of the number of cancers
currently still occurring for exposures up to 50 years in the past.
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Figure 3 Attributable cancer estimates using a non-age-adjusted
attributable fraction (solid lines) and age-adjusted attributable fraction*
(dashed lines) and range of turnover cohort recruitment ages, RR¼2.
*Results for the ‘age-adjusted attributable fraction’ are obtained by partitioning
Ne(REP) from equation (2) by age-group, giving proportions of the population
exposed and attributable fraction by age group; these are applied to age-specific
cancer numbers to obtain occupation-attributable numbers.
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Figure 4 Sources of bias in the calculation of an overall attributable fraction.
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Figure 5 (A) Effect of change in length of the solid tumour risk exposure period and shortened latencies on proportion of the population exposed at
different levels of exposed number point estimates. (B) Effect of change in annual staff turnover on the proportion of the population exposed at different
levels of exposed number point estimates.
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on whether it was based on mortality or on incidence data. The
difference depended on the ratios of deaths to registrations in the
cancers that were included (i.e., on survival rates). A combined AF
based on attributable deaths would have under-weighted the
contribution of non-fatal cancers, such as non-melanoma skin
cancer, which is rarely fatal but occurs in relatively large numbers.
On the other hand, a combined AF based on incidence would have
given all cancers equal weighting so that the large numbers of non-
melanoma skin cancers would have made a disproportionately
large contribution. This indicates the value of using such estimates
as Disability-Adjusted Life Years in conjunction with attributable
numbers to estimate an overall AF weighted according to the
relative severity of the cancer outcome (especially as survival
improves).
Figure 4 outlines the main sources of bias and uncertainty and
where they occur in the estimation process. Work is underway to
estimate credibility intervals that take into account these sources
of bias.
The most influential sources of underestimation of the overall
AF are likely to be (1) the choice of exposures we have made and
(2) the existence of as yet unidentified workplace carcinogens.
Only occupational carcinogens classified by the end of 2008 by
IARC as 1 and 2A carcinogens have been included. Other cancer
sites, for example, for asbestos have been classified as group 1
or 2A since then, and the review process for newly emerging
carcinogens is ongoing (IARC, 2012). These sources of bias are,
however, not thought likely to affect the relative rankings of the
carcinogens.
For AF estimates for individual carcinogens, we consider the
most important sources of bias to be as follows: (1) assumptions
about cancer latency and workplace staff turnover and their effect
on the estimates of the number of people ever exposed; (2) the
absence of estimates of the proportion in the workplace exposed
(i.e., where CAREX estimates are not available) for some more
recently identified carcinogenic exposures or exposures charac-
terised by occupation only; and (3) the general scarcity of
exposure-level measurement data and dose–response RR esti-
mates, leading to the adoption of judgemental allocation of
industrial sectors to ‘higher’ and ‘lower’ exposure levels and
matching to appropriate RR estimates. The lack of individual
exposure data is a well-recognised problem; there are few good
biomarkers and little monitoring on an individual level for most of
the exposures considered in this study.
Of these, the first, although possibly substantial, source of bias
will generally affect all the exposures equally, and thus will not
affect rank orders. Figure 5 gives an indication of how change in
the assumed length of the REP affects estimates of the proportions
of the population exposed (Pr(E) in equation (4) above). For a
prevalent estimate of 100000 individuals exposed (n0 in equation
(2), from Labour Force Survey or CAREX data for example), Pr(E)
increases by about 0.4% in absolute value for each additional 10
years added to the REP. For n0¼500000, the rate of increase is
under 2% per additional 10 years. However, this means that if the
solid tumour REP (1956–1995) has been overestimated by 10 years
(i.e., it should have been 1966–1995) Pr(E) will be overestimated
by 19% of the true value, or if the true REP is 1976–1995 Pr(E) will
be overestimated by 54% and 125% for a true REP of 1986–1995.
These percentage errors are constant across the prevalence estimates
(n0). This will have a substantial impact on the estimate of AF.
For the solid tumour REP, proportions of the population
exposed increase approximately in proportion to the increase in
turnover, illustrated in Figure 5B for estimates of staff turnover
from 5 to 25% a year.
There is no good comprehensive British source of the
proportion in the workplace exposed to carcinogenic agents such
as a job exposure matrix or a comprehensive national exposure
database. Therefore, where there are no CAREX estimates (for
mineral oils, TCDD (2,3,7,8-tetrachlorodibenzodioxin-p-dioxins),
non-arsenical pesticides, welders, painters, hairdressers and
barbers, and shift work), we have assumed that all those recorded
by occupation are exposed, although these are then matched to
appropriate occupation-based rather than agent-based risk esti-
mates. This absence of estimates of the proportion exposed may
upwardly bias the AF estimates for exposures. If, for example, only
half rather than all of those identified as painters are actually
exposed to the unidentified carcinogen(s), then proportions
exposed will be halved.
There is an absence of good epidemiological studies for some
agents, particularly an absence of dose–response data (often due
to a paucity of good exposure measurement data) and of estimates
of risk at low levels of exposure. The use of categorical allocation of
industrial sectors to higher or lower levels may cause under- or
overestimation. In instances where ‘lower’-exposed groups have
been allocated a zero excess risk, that is, RR¼1, underestimation
is probable (e.g., lung cancer due to low-level beryllium, cadmium,
chromium, inorganic lead, strong inorganic acid mists exposure;
brain and stomach cancers due to low-level inorganic lead
exposure; nasopharyngeal and sinonasal cancers due to low-level
formaldehyde exposure). When there were insufficient dose–
response data to obtain a low-exposure RR, we estimated this
based on all available data within the project. In instances where
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Figure 6 Increase in the attributable fraction for a unit increase in
relative risk by proportion of the population exposed (Pr(E)). (A) Changes
in relative risk from 1 to 2. (B) Changes in relative risk from 1 to 10.
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possibility. Examples of this included oesophageal and cervical
cancers due to low-level tetrachloroethylene exposure; sinonasal
cancers due to low-level wood dust, chromium and mineral oil
exposure; and liver cancers due to low-level vinyl chloride
monomer exposure (Van Tongeren et al, 2012).
Figures 6A and B show, for the range of population proportions
exposed and the range of RRs encountered in this study, how a
unit change of RR affects the estimate of AF. For example, if the RR
for breast cancer due to shift work was 0.1 units lower than the RR
used (1.41 instead of 1.51), the AF is reduced by 20% (proportion
of the population exposed¼0.09) – Figure 6A. If the zero excess
risk allocated for lung cancer due to low exposure to inorganic
lead, cadmium and chromium respectively is increased by 0.1 units
(RR¼1.1), the AFs for men increase by 180%, 170% and 50%,
respectively (for beryllium and strong inorganic acid mists with
small numbers exposed at low level, the change is negligible). If the
estimated low-exposure RRs for sinonasal cancer due to exposure
to chromium, mineral oils and wood dust respectively are
decreased by 1 unit (from RR¼3.42 to 2.42 (Figure 6B), 1.85 to
1 and 2.05 to 1.05 respectively; the proportions of the populations
exposed are 0.02, 0.30 and 0.09, respectively), AFs for men
decrease by 10% and 40% for chromium and mineral oils, but by
only 4% for wood dust (as relatively few are classified as low
exposed).
Ongoing work has shown that the bias from using Levin’s
approach with RRs adjusted for confounding factors (Greenland,
1984; Rockhill et al, 1998) is close to the ratio of adjusted to
unadjusted relative risk and generally likely to be small, and that
the use of equation (6) to combine AFs across exposures
minimises unavoidable bias.
CONCLUSIONS
In summary, the methodology developed here has allowed us to
estimate the overall size of the burden of occupational cancer in
Britain, and to assess the relative contributions to that burden
from different workplace carcinogens and occupations that have
been associated with increased risk of cancer, and from different
industries (Hutchings and Rushton, 2012). This allows prioritisa-
tion of interventions to address workplace cancer. The methods
are robust with respect to the study’s objectives, and are adaptable
to the limited availability of good exposure data in particular. In
instances where better exposure data and dose–response risk
estimates are available, the methods can easily be adapted to
use these data for more sophisticated modelling. Assumptions
and generalisations have been made to enable all of Britain’s
occupational carcinogens to be addressed on a consistent basis,
but the methods allow any parameters to be replaced so that data
from other countries and regions and representing change in the
future can be substituted. On the basis of the AF methodology
described here, a method has also been developed to estimate the
future burden of occupational cancer, which can be used to inform
strategies for risk reduction (Hutchings and Rushton, 2011). REPs
are projected forward in time to estimate AFs for a series of
forecast target years based on past and projected exposure trends
and under targeted reduction scenarios.
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